Follow on Google News News By Tag * Alopecia * Pattern Baldness * Women * Hair Loss * Hair * Hair Treatment * Jernigans * Raleigh * Laser * More Tags... Industry News News By Place Country(s) Industry News
Follow on Google News | MEP-90 Laser Treatment for Pattern Baldness in Women Now Available at Jernigans in RaleighThe MEP-90 Hair Growth Stimulation System, developed and manufactured by Midwest RF, is now available at Jernigan’s Hair Replacement Clinic in Raleigh. The MEP-90 is the only FDA-cleared device proven to regrow hair on female patients.
By: Susan Jernigan The MEP-90 is a cutting-edge development in the treatment of a condition for which there are few medical options available. It is proven to promote hair growth and reduce the rate of hair loss of females with androgenic alopecia. The MEP-90 utilizes a fixed schedule of 100% computer-controlled Low Level Laser Therapy (LLLT) to the scalp area. It is a contoured laser with 82 low-level laser light diodes completely covering the scalp with measured light stimulation. During the treatments, the laser light energy stimulates blood flow and cellular metabolism in the scalp, using a scientific principal called photobiostimulation. The MEP-90 is a Class II medical device that is offered to licensed physicians only and available by prescription only. It meets the same FDA laser safety codes as lasers employed in Lasik surgery, laser pain therapy and other medical laser procedures. Unlike lasers used to cut, burn, or vaporize hair follicles, the MEP-90’s unique ‘cold’ lasers stimulate hair growth with little or no sensation to the patient. Clinical studies suggest that twice-weekly 20- minute treatments with the MEP-90 laser over the course of six months produces remarkable results in a vast majority of patients. A 21-month clinical study, sanctioned by the Institutional Review Board (IRB), validated the 10-week results of the MEP-90, which demonstrated that 92% of the subjects experienced an increased hair count of >10%, with 57% demonstrating an increase of >30%. After 36 treatments, 97% of the subject population demonstrated an increased hair count of >50%. No subject in the study experienced any adverse effects from the treatment. Jernigan’s own Natasha Achterberg, Research Coordinator, along with Dr. Grant Koher, Principal Investigator, performed the FDA study to validate the MEP-90 device. While it was difficult to set up the FDA study, Achterberg was involved in interviewing prospective patients, updating medical records, photography, and performing treatments on over 160 women. “The study exceeded our expectations,” Achterberg will be conducting consultations and faculty training at Jernigan’s Hair Replacement Clinic. “The exciting results of the clinical study, and FDA approval, opens the door to new hope for the estimated 27 million women for whom female pattern baldness is a devastating reality,” says Helmur Keidl, President of Midwest RF,LLC, an established designer and manufacturer of medical devices. Achterberg also shares Keidl’s excitement over the possibilities the MEP-90 laser gives to women with female pattern baldness. “During the study,” she said. “Women expressed their gratitude, as they didn’t have any options really to help them. It was amazing to help them through it.” # # # Jernigan's Hair Replacement Clinic has been the number one leading hair replacement clinic in the Raleigh, North Carolina area for over thirty years. We have been helping men and women with the latest techniques in hair replacement and restoration procedures for over 30 years. We specialize in medical, non-medical and treatments for hair loss. Our mission is to educate you about hair loss and provide you with a real solution to your hair loss using state-of-the- Contact us at (919) 787-2401. Visit our website: www.jernigans.com Like us on Facebook: http://www.facebook.com/? End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|